Revenue Breakdown
Composition ()
No data
Revenue Streams
Jin Medical International Ltd (ZJYL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Wheelchair, accounting for 72.9% of total sales, equivalent to $7.69M. Another important revenue stream is Wheelchair components and others. Understanding this composition is critical for investors evaluating how ZJYL navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Jin Medical International Ltd maintains a gross margin of 24.31%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -4.60%, while the net margin is 0.09%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively ZJYL converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ZJYL competes directly with industry leaders such as RVP and COCH. With a market capitalization of $21.51M, it holds a leading position in the sector. When comparing efficiency, ZJYL's gross margin of 24.31% stands against RVP's 16.72% and COCH's -383.33%. Such benchmarking helps identify whether Jin Medical International Ltd is trading at a premium or discount relative to its financial performance.
